Trader consensus at 99% against removal via the 25th Amendment before 2027 stems from the lack of any verified reports of presidential incapacity, consistent public statements affirming fitness for office, and institutional barriers including cabinet composition and congressional majorities required for invocation or sustained action. Primary drivers include stable health indicators, ongoing policy execution without disruption, and historical precedent showing the amendment's use remains rare absent acute medical or cognitive crises. Realistic scenarios that could still shift odds include sudden verifiable health events triggering cabinet review, major documented declines prompting bipartisan pressure, or unforeseen legal challenges altering succession dynamics within the resolution window ending December 31, 2026.